Nurse Practitioner, Acute Care · Worcester, MA
NPI
1881833101
Since 2009
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
55 Lake Ave N, Department of Medicine
Worcester, MA, 01655
Phone (508) 856-3206
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
618 services
Medicare patients, 2024
372
Average age 70
Drug cost, 2024
$3.6M
8,189 prescriptions
Company payments, 2025
$108
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christine V Hoogasian was code 99214 (office e&m - established), 581 times for 355 patients. In total Christine V Hoogasian billed 618 services in 5 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 581 | 355 | $60.03 | $35K |
| 99442 Telephone Services | Office | 27 | 24 | $59.72 | $1,612 |
By year: 2022 $40K for 660 services; 2023 $42K for 709 services; 2024 $37K for 618 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christine V Hoogasian prescribed most often to Medicare patients was Trulicity (Dulaglutide), with 645 prescriptions and refills. In total Christine V Hoogasian wrote 8,189 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | 645 | 851 | 134 | $810K |
| Ozempic Semaglutide | 602 | 786 | 125 | $717K |
| Metformin Hcl Generic | 599 | 1,349 | 158 | $5,254 |
| Jardiance Empagliflozin | 519 | 922 | 124 | $525K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 409 | 742 | 121 | $56K |
| Metformin Hcl Er Metformin Hcl | 322 | 746 | 91 | $4,355 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 268 | 535 | 74 | $130K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 205 | 384 | 74 | $21K |
| Mounjaro Tirzepatide | 199 | 221 | 38 | $221K |
| Novolog Flexpen Insulin Aspart | 185 | 293 | 65 | $45K |
| Gabapentin Generic | 176 | 287 | 44 | $2,819 |
| Glipizide Er Glipizide | 171 | 344 | 43 | $2,899 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 168 | 340 | 68 | $16K |
| Atorvastatin Calcium Generic | 155 | 364 | 49 | $2,383 |
| Lisinopril Generic | 152 | 391 | 48 | $1,760 |
Brand drugs: 4,383 claims; generic drugs: 2,665 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christine V Hoogasian $108 ($108 in general payments such as food, travel and fees) from 1 company. The largest payer was Madrigal Pharmaceuticals with $108.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 1 | $108 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.